METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA Russian patent published in 2009 - IPC A61M15/00 A61K38/20 A61P11/06 

FIELD: medicine; pulmonology.

SUBSTANCE: baseline therapy is combined with introduction of Ronkoleukine inhaled in dosage 250 thousand ME with using nebuliser, and injected simultaneously. Introduction takes two stages, herewith at the first stage Ronkoleukine is injected intravenously drop-by-drop in dosage 250 thousand ME within course 3 procedures every 72 hours, while at the second stage Ronkoleukine is injected every 2 weeks hypodermically in external surface of a shoulder in dosage 250 thousand ME within course 4-6 procedures.

EFFECT: normalised immune disorders and relieved endobronchial inflammations.

2 tbl, 3 ex